Cynthia A Moylan MD MHS
Hepatology & Liver Transplantation
Associate Professor, Medicine, Duke University School of Medicine
Join to View Full Profile
905 S Lasalle StDurham, NC 27710
Dr. Moylan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Transplant Hepatology, 2008 - 2009- Duke University HospitalFellowship, Gastroenterology, 2005 - 2008
- Duke University HospitalResidency, Internal Medicine, 2002 - 2005
University of Miami Leonard M. Miller School of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2002 - 2026
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial ...Wee Han Ng, Yee Hui Yeo, Hyunseok Kim, Ekihiro Seki, Jonathan Rees
Hepatology. 2025-04-02 - 1 citationsOsteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH.Jason D Coombes, Paul P Manka, Marzena Swiderska-Syn, Danielle T Vannan, Antonio Riva
Liver International. 2025-04-01 - 2 citationsThe Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.Elliot B Tapper, David Goldberg, Neehar D Parikh, Norah A Terrault, Nicole Welch
The American Journal of Gastroenterology. 2025-03-01
Journal Articles
- Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic FibrosisSteve S Choi, Julius Wilder, Cynthia A Moylan, JAMA
Press Mentions
Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic FibrosisOctober 31st, 2018
Yuval Patel Awarded First Prize for Poster at Durham VA's Research Week EventMay 27th, 2016
Grant Support
- Genomic Imprinting in the Development of NAFLDDUKE UNIVERSITY2024–2028
- Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosisUT SOUTHWESTERN MEDICAL CENTER2023–2027
- Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosisUT SOUTHWESTERN MEDICAL CENTER2023–2027
- Southern Liver Health CohortNORTH CAROLINA STATE UNIVERSITY RALEIGH2021–2027
- Southern Liver Health CohortNORTH CAROLINA STATE UNIVERSITY RALEIGH2021–2027
- Prediction and Prevention of Hepatic Decompensation in Patients with CirrhosisDUKE UNIVERSITY2021–2026
- Prediction and Prevention of Hepatic Decompensation in Patients with CirrhosisDUKE UNIVERSITY2021–2026
- Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapyDURHAM VA MEDICAL CENTER2021–2025
- Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapyDURHAM VA MEDICAL CENTER2021–2025
- Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapyDURHAM VA MEDICAL CENTER2021–2025
- Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapyDURHAM VA MEDICAL CENTER2021–2025
- Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapyDURHAM VA MEDICAL CENTER2021–2025
- Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapyDURHAM VA MEDICAL CENTER2021–2025
- Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapyDURHAM VA MEDICAL CENTER2021–2025
Professional Memberships
- Member
- American Association for the Study of Liver DiseasesMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
